FBXL19
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1630947572rs7200879AGrs72008795.00E-19ACENOCOUMAROLCYP2C9 PROTEIN, HUMAN|VITAMIN K EPOXIDE REDUCTASES|VKORC1 PROTEIN, HUMAN|MIXED FUNCTION OXYGENASES|CYTOCHROME P-450 CYP2C9|ANTICOAGULANTS|ARYL HYDROCARBON HYDROXYLASESAcenocoumarol maintenance dosageHPOID:0005110DOID:1247AintronGWASdb_drug
1630942625rs10782001GArs107820019.00E-10PsoriasisHPOID:0003765DOID:8893GintronGWASdb_trait
1630942625rs10782001GArs107820012.60E-07Red blood cell traitsHPOID:0001877DOID:74GintronGWASdb_trait
1630946506rs10782002AGrs107820021.11E-07Red blood cell traitsHPOID:0001877DOID:74GintronGWASdb_trait
1630947572rs7200879AGrs72008795.00E-19Acenocoumarol maintenance dosageHPOID:0005110DOID:1247AintronGWASdb_trait
1630953202rs1458202GArs14582025.73E-08Red blood cell traitsHPOID:0001877DOID:74GintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000099364.16 FBXL19 609085